Rezolute Inc. (RZLT)

[Whalatane]

RZLT CC. key pts
1) Co is unlikely to advance drug themselves ( so probably no capital raise after this :--). Mgt says to big a market to take on by themselves .
2( They would expect to see BCVA improvement by 6 mths ...theres a lag response to reducing retinal thickness .
3) Retinal specialists say multiple eye disease indications may benefit from this drug RZ402 ...far larger / longer trials with 3 mth , 6 mth and 12 mth data warranted . They want to start RZ402 early to delay need for eye injections and then later use with the injections if needed. Many ways to use the drug ...standalone and in combination.

Kiwi